PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22038446-3	2012	The aim of this study was therefore to analyse alterations in the expression of M-CSF, VEGF and TGF-ss1 after treatment with enoxaparin in patients with long bone fracture to investigate the effect of LMWH on human fracture healing.	Enoxaparin	125-135	colony stimulating factor 1	Homo sapiens	80-85	
22038446-7	2012	RESULTS: M-CSF serum concentrations were found to be significantly higher only at 48 weeks after surgery in enoxaparin.	Enoxaparin	108-118	colony stimulating factor 1	Homo sapiens	9-14	
22038446-10	2012	CONCLUSION: This is the first comparative systemic measurement of M-CSF, VEGF and TGF-ss1 serum levels in patients with and without enoxaparin after long bone fracture.	Enoxaparin	132-142	colony stimulating factor 1	Homo sapiens	66-71	
22038446-11	2012	Significant differences of the expression of the growth factors after enoxaparin therapy were only observed at week 48 after surgery for M-CSF and TGF-ss1.	Enoxaparin	70-80	colony stimulating factor 1	Homo sapiens	137-142